| Kay W Quick, APRN | |
|
2711 S Rouse St Ste F, Pittsburg, KS 66762-6621 | |
| (620) 232-9000 | |
| (620) 232-9005 |
| Full Name | Kay W Quick |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 24 Years |
| Location | 2711 S Rouse St Ste F, Pittsburg, Kansas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134189848 | NPI | - | NPPES |
| 200357290B | Medicaid | KS | |
| 200515050A | Medicaid | OK |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363L00000X | Nurse Practitioner | 45353 (Kansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Via Christi Hospital Pittsburg Inc | Pittsburg, KS | Hospital |
| Girard Medical Center | Girard, KS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hospital District No 1 Crawford County | 3476464538 | 29 |
News Archive
Today, at the occasion of the 4th DNDi Partners' Meeting in Rio de Janeiro, Brazil, Dr Carlos Gadelha, Secretary of Science, Technology and Strategic Products, Brazilian Ministry of Health, announced that Brazil's National Health Surveillance Agency (ANVISA) granted registration of a new paediatric dosage form of benznidazole, developed through a partnership between the Pernambuco State Pharmaceutical Laboratory (LAFEPE) of Brazil and the Drugs for Neglected Diseases initiative (DNDi).
The Leukemia & Lymphoma Society announced that it has passed the $1 billion mark in research investment, a significant milestone in the cancer research landscape as LLS continues its 65 year pursuit of advancing breakthrough therapies, finding cures and ensuring access to life-saving therapies for all blood cancer patients.
The University of Texas at Arlington has received a new $227,000 grant funded through the federal government's Medical Technology Enterprise Consortium to develop the manufacturing process for the REHEAL glove, a bioengineered healing glove that delivers medicine to injured hands to speed up healing.
Abbott today announced the European approval and launch of its TREK™ Coronary Dilatation Catheter for the treatment of coronary artery disease. The TREK system represents a new approach to balloon catheter design, and provides physicians with a high-performing option for treating challenging lesions and difficult-to-reach blockages. Abbott received CE Mark for the TREK system earlier this year.
Cognitive neuroscientists at the Swedish medical university Karolinska Institutet (KI) have succeeded in making subjects perceive the bodies of mannequins and other people as their own.
› Verified 5 days ago
| Entity Name | Hospital District No 1 Crawford County |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508897182 PECOS PAC ID: 3476464538 Enrollment ID: O20040112000337 |
News Archive
Today, at the occasion of the 4th DNDi Partners' Meeting in Rio de Janeiro, Brazil, Dr Carlos Gadelha, Secretary of Science, Technology and Strategic Products, Brazilian Ministry of Health, announced that Brazil's National Health Surveillance Agency (ANVISA) granted registration of a new paediatric dosage form of benznidazole, developed through a partnership between the Pernambuco State Pharmaceutical Laboratory (LAFEPE) of Brazil and the Drugs for Neglected Diseases initiative (DNDi).
The Leukemia & Lymphoma Society announced that it has passed the $1 billion mark in research investment, a significant milestone in the cancer research landscape as LLS continues its 65 year pursuit of advancing breakthrough therapies, finding cures and ensuring access to life-saving therapies for all blood cancer patients.
The University of Texas at Arlington has received a new $227,000 grant funded through the federal government's Medical Technology Enterprise Consortium to develop the manufacturing process for the REHEAL glove, a bioengineered healing glove that delivers medicine to injured hands to speed up healing.
Abbott today announced the European approval and launch of its TREK™ Coronary Dilatation Catheter for the treatment of coronary artery disease. The TREK system represents a new approach to balloon catheter design, and provides physicians with a high-performing option for treating challenging lesions and difficult-to-reach blockages. Abbott received CE Mark for the TREK system earlier this year.
Cognitive neuroscientists at the Swedish medical university Karolinska Institutet (KI) have succeeded in making subjects perceive the bodies of mannequins and other people as their own.
› Verified 5 days ago
| Entity Name | Minimally Invasive And Bariatric Surgery, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932344538 PECOS PAC ID: 2961566294 Enrollment ID: O20090130000305 |
News Archive
Today, at the occasion of the 4th DNDi Partners' Meeting in Rio de Janeiro, Brazil, Dr Carlos Gadelha, Secretary of Science, Technology and Strategic Products, Brazilian Ministry of Health, announced that Brazil's National Health Surveillance Agency (ANVISA) granted registration of a new paediatric dosage form of benznidazole, developed through a partnership between the Pernambuco State Pharmaceutical Laboratory (LAFEPE) of Brazil and the Drugs for Neglected Diseases initiative (DNDi).
The Leukemia & Lymphoma Society announced that it has passed the $1 billion mark in research investment, a significant milestone in the cancer research landscape as LLS continues its 65 year pursuit of advancing breakthrough therapies, finding cures and ensuring access to life-saving therapies for all blood cancer patients.
The University of Texas at Arlington has received a new $227,000 grant funded through the federal government's Medical Technology Enterprise Consortium to develop the manufacturing process for the REHEAL glove, a bioengineered healing glove that delivers medicine to injured hands to speed up healing.
Abbott today announced the European approval and launch of its TREK™ Coronary Dilatation Catheter for the treatment of coronary artery disease. The TREK system represents a new approach to balloon catheter design, and provides physicians with a high-performing option for treating challenging lesions and difficult-to-reach blockages. Abbott received CE Mark for the TREK system earlier this year.
Cognitive neuroscientists at the Swedish medical university Karolinska Institutet (KI) have succeeded in making subjects perceive the bodies of mannequins and other people as their own.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kay W Quick, APRN 2711 S Rouse St Ste F, Pittsburg, KS 66762-6621 Ph: (620) 232-9000 | Kay W Quick, APRN 2711 S Rouse St Ste F, Pittsburg, KS 66762-6621 Ph: (620) 232-9000 |
News Archive
Today, at the occasion of the 4th DNDi Partners' Meeting in Rio de Janeiro, Brazil, Dr Carlos Gadelha, Secretary of Science, Technology and Strategic Products, Brazilian Ministry of Health, announced that Brazil's National Health Surveillance Agency (ANVISA) granted registration of a new paediatric dosage form of benznidazole, developed through a partnership between the Pernambuco State Pharmaceutical Laboratory (LAFEPE) of Brazil and the Drugs for Neglected Diseases initiative (DNDi).
The Leukemia & Lymphoma Society announced that it has passed the $1 billion mark in research investment, a significant milestone in the cancer research landscape as LLS continues its 65 year pursuit of advancing breakthrough therapies, finding cures and ensuring access to life-saving therapies for all blood cancer patients.
The University of Texas at Arlington has received a new $227,000 grant funded through the federal government's Medical Technology Enterprise Consortium to develop the manufacturing process for the REHEAL glove, a bioengineered healing glove that delivers medicine to injured hands to speed up healing.
Abbott today announced the European approval and launch of its TREK™ Coronary Dilatation Catheter for the treatment of coronary artery disease. The TREK system represents a new approach to balloon catheter design, and provides physicians with a high-performing option for treating challenging lesions and difficult-to-reach blockages. Abbott received CE Mark for the TREK system earlier this year.
Cognitive neuroscientists at the Swedish medical university Karolinska Institutet (KI) have succeeded in making subjects perceive the bodies of mannequins and other people as their own.
› Verified 5 days ago
Stacey E Bacon, NP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1701 S Broadway St, Pittsburg, KS 66762 Phone: 620-235-4452 | |
Tracy M Orellana, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 3011 N Michigan St, Pittsburg, KS 66762 Phone: 620-240-5600 | |
Anna Christine Kill, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 3011 N Michigan St, Pittsburg, KS 66762 Phone: 888-777-9170 | |
Judith A Coltharp, FNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1 Mt Carmel Way, Pittsburg, KS 66762 Phone: 620-231-6100 Fax: 620-235-7913 | |
Ciri D Corbin, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 3011 N Michigan St, Pittsburg, KS 66762 Phone: 620-231-9873 | |
Sarah Diane Stinebaugh, MSN, APRN, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1702 S Olive St, Pittsburg, KS 66762 Phone: 620-704-7789 | |
Miss Sheina Michelle Huffman, ARNP-CNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 3011 N Michigan St, Pittsburg, KS 66762 Phone: 620-231-9873 Fax: 620-231-5062 |